NetScientific PLC (AIM:NSCI) has noted that portfolio company PDS Biotechnology has completed enrolment for the next stage of its VERSATILE-002 head and neck cancer study.
VERSATILE-002 is a Phase 2, open-label, multicenter study of the efficacy and safety of PDS drug 0101 in combination with Merck’s Keytruda (pembrolizumab).
Kodal Minerals PLC (AIM:KOD) has said it expects to apply for formal government approval early next year to construct its dense media separation (DMS) processing plant at its Bougouni lithium project in southern Mali.
After completing concept designs and the tailings storage layout and concept design, the company said it is finalising engineering and environmental work to support formal approval for the DMS option from the Mali government.
Chesnara PLC (LSE:CSN) said it has now received all of the necessary court and regulatory approvals for the transaction to acquire Dutch insurer Conservatrix.
The acquisition will formally complete on 1 January 2023, when Conservatrix’s insurance portfolio will be acquired by Waard Leven, Chesnara’s Dutch closed book operation.
Shield Therapeutics PLC (AIM:STX, OTCQX:SHIEF)has published details of the open offer that will accompany its recent US$18.5mln fundraising. The offer, at 6p a share, aims to raise £3.9mln (more here).
Bushveld Minerals Limited (AIM:BMN, OTC:BSHVF) announced that Ms Jacqueline Musiitwa will stand down as a non-exec effective immediately, having accepted a role with the US Agency for International Development.
Keywords Studios PLC (AIM:KWS, OTC:KYYWF) said it has completed the acquisition of Helpshift Inc on the terms previously announced.
Zanaga Iron Ore Co Ltd (AIM:ZIOC, OTC:ZNGGF) said the acquisition of all of Glencore Projects' 50%-plus one share interest in Jumelles has now occurred and the consideration shares have been admitted to trading on AIM. (more here)